KOVANAZE

Peak

oxymetazoline hydrochloride; tetracaine hydrochloride

NDANASALSPRAY, METERED
Approved
Jun 2016
Lifecycle
Peak
Competitive Pressure
8/100

Loss of Exclusivity

LOE Date
Apr 2, 2030
49 months away
Patent Expiry
Apr 2, 2030

Patent Records (2)

Patent #ExpiryTypeUse Code
8580282
Apr 2, 2030
Product
U-1876
9308191
Apr 2, 2030
Product
U-1876
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history